Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 129, 2023 - Issue 3
2,163
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Acute kidney injury in COVID 19 – an update on pathophysiology and management modalities

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 626-639 | Received 05 Sep 2020, Accepted 21 Nov 2020, Published online: 15 Dec 2020

References

  • Abrishami, A., et al., 2020. Clinical course, imaging features, and outcomes of COVID-19 in kidney transplant recipients. European urology, 78 (2), 281–286.
  • Adapa, S., et al., 2020. COVID-19 and renal failure: challenges in the delivery of renal replacement therapy. Journal of clinical medicine research, 12 (5), 276–285.
  • Alberici, F., et al., 2020. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney international, 97 (6), 1083–1088.
  • Alge, J.L. and Arthur, J.M., 2015. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clinical journal of the American Society of Nephrology : CJASN, 10 (1), 147–155.
  • Ali, H., et al., 2020. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. Renal failure, 42 (1), 393–397.
  • Alshukry, A., et al., 2020. Clinical characteristics of Coronavirus Disease 2019 (COVID-19) patients in Kuwait. Infectious Diseases (except HIV/AIDS), preprint.
  • Annat, G., et al., 1983. Effect of PEEP ventilation on renal function, plasma renin, aldosterone, neurophysins and urinary ADH, and prostaglandins. Anesthesiology, 58 (2), 136–141.
  • Anti-2019-nCoV Volunteers, Li, Z., et al., 2020. Caution on kidney dysfunctions of COVID-19 patients. Infectious Diseases (except HIV/AIDS), preprint.
  • Arentz, M., et al., 2020. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA, 323 (16), 1612–1614.
  • Argenziano, M. G., et al., 2020. Characterization and clinical course of 1000 Patients with COVID-19 in New York: retrospective case series. Intensive Care and Critical Care Medicine, preprint.
  • Arpali, E., et al., 2020. Case report: a kidney transplant patient with mild COVID‐19. Transplant infectious disease, 22 (4), e13296.
  • Banerjee, D., et al., 2020. COVID-19 infection in kidney transplant recipients. Kidney international, 97 (6), 1076–1082.
  • Borba, M.G.S., et al., for the CloroCovid-19 Team, 2020. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomised clinical trial. JAMA network open, 3 (4), e208857.
  • Borobia, A. M., et al., COVID@HULP working team, 2020. A cohort of patients with COVID-19 in a major teaching hospital in Europe. Infectious Diseases (except HIV/AIDS), preprint.
  • Bussalino, E., et al., 2020. Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS‐CoV‐2 pneumonia: a case report. American journal of transplantation, 20 (7), 1922–1924.
  • Cao, J., et al., 2020. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (15), 748–755.
  • Chang, J.-H., et al., 2019. Donor’s APOL1 risk genotype and “second hits” associated with de novo collapsing glomerulopathy in deceased donor kidney transplant recipients: a report of 5 cases. American journal of kidney diseases : the official journal of the National Kidney Foundation, 73 (1), 134–139.
  • Chen, F., et al., 2020a. Clinical characteristics and risk factors for mortality among inpatients with COVID‐19 in Wuhan. Clinical and translational medicine, 10 (2), e40.
  • Chen, N., et al., 2020b. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395 (10223), 507–513.
  • Chen, T., et al., 2020c. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ, 368, m1091.
  • Cheng, D., et al., 2020a. Coronavirus disease 2019 in renal transplant recipients: report of two cases. Transplant infectious disease, 22 (5), e13329.
  • Cheng, Y., et al., 2020b. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international, 97 (5), 829–838.
  • Crespo, M., et al., 2020. COVID‐19 in elderly kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 20 (10), 2883–2889.
  • D'Alto, M., et al., 2018. Right heart catheterization for the diagnosis of pulmonary hypertension: controversies and practical issues. Heart failure clinics, 14 (3), 467–477.
  • Darmon, M., et al., 2009. Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation. Intensive care medicine, 35 (6), 1031–1038.
  • Deng, Y., et al., 2020. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chinese medical journal, 133 (11), 1261–1267.
  • Diao, B., et al., 2020. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Infectious Diseases (except HIV/AIDS), preprint.
  • Edrees, F., Li, T., and Vijayan, A., 2016. Prolonged intermittent renal replacement therapy. Advances in chronic kidney disease, 23 (3), 195–202.
  • Fernández‐Ruiz, M., et al., 2020. COVID‐19 in solid organ transplant recipients: a single‐center case series from Spain. American journal of transplantation, 20 (7), 1849–1858.
  • Fiddian-Green, R.G. and Silen, W., 1975. Mechanisms of disposal of acid and alkali in rabbit duodenum. The American journal of physiology, 229 (6), 1641–1648.
  • Gabarre, P., et al., 2020. Acute kidney injury in critically ill patients with COVID-19. Intensive care medicine, 46 (7), 1339–1348.
  • Gattinoni, L., et al., 2020. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive care medicine, 46 (6), 1099–1102.
  • Gaudry, S., et al., 2020. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomized clinical trials. The Lancet, 395 (10235), 1506–1515.
  • Genovese, G., et al., 2010. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (New York, N.Y.), 329 (5993), 841–845.
  • Ghani, R.A., et al., 2006. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton, Vic.), 11 (5), 386–393.
  • Grasselli, G., et al., for the COVID-19 Lombardy ICU Network, 2020. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA, 323 (16), 1574.
  • Guan, W., et al., China Medical Treatment Expert Group for Covid-19, 2020. Clinical characteristics of coronavirus disease 2019 in China. The New England journal of medicine, 382 (18), 1708–1720.
  • Guillen, E., et al., 2020. Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? American journal of transplantation, 20 (7), 1875–1878.
  • Guo, T., et al., 2020. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology, 5 (7), 811.
  • Gupta, S., et al., for the STOP-COVID Investigators, 2020. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA internal medicine, 180 (11), 1436.
  • He, Q., et al., 2020. Single‐cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: a potential pathway of COVID‐19 infection. Molecular genetics & genomic medicine, 8 (10), e1442.
  • Hirsch, J.S., et al., 2020. Acute kidney injury in patients hospitalized with COVID-19. Kidney international, 98 (1), 209–218.
  • Hong, K.S., et al., 2020. Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: a brief descriptive study. Yonsei medical journal, 61 (5), 431–437.
  • HOPE COVID-19 Investigators, Uribarri, A., et al., 2020. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. Journal of nephrology, 33 (4), 737–745.
  • Hsu, J.J., et al., 2020. COVID‐19 in a high‐risk dual heart and kidney transplant recipient. American journal of transplantation, 20 (7), 1911–1915.
  • Hu, L., et al., 2020. Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China. Infectious Diseases (except HIV/AIDS), preprint.
  • Huang, C., et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395 (10223), 497–506.
  • Husain-Syed, F., Slutsky, A.S., and Ronco, C., 2016. Lung-kidney cross-talk in the critically ill patient. American journal of respiratory and critical care medicine, 194 (4), 402–414.
  • Ibrahim, Y.F., et al., 2020. Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein. Inflammopharmacology, 28 (1), 215–230.
  • Imam, Z., et al., 2020. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID‐19 patients in Michigan, United States. Journal of internal medicine, 288 (4), 469–476.
  • Joannidis, M., et al., 2020. Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive care medicine, 46 (4), 654–672.
  • Johnson, K.M., et al., 2020. Managing COVID-19 in renal transplant recipients: a review of recent literature and case supporting corticosteroid-sparing immunosuppression. Pharmacotherapy, 40 (6), 517–524.
  • Kang, D., et al., 2015. The risk factors and prognostic implication of acute pulmonary edema in resuscitated cardiac arrest patients. Clinical and experimental emergency medicine, 2 (2), 110–116.
  • Kates, O.S., et al., 2020. Earliest cases of coronavirus disease 2019 (COVID‐19) identified in solid organ transplant recipients in the United States. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 20 (7), 1885–1890.
  • Khokhar, M., et al., 2020. Viricidal treatments for prevention of coronavirus infection. Pathogens and global health, 114 (7), 349–311.
  • Kielstein, J.T., et al., 2004. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. American journal of kidney diseases, 43 (2), 342–349.
  • Kissling, S., et al., 2020. Collapsing glomerulopathy in a COVID-19 patient. Kidney international, 98 (1), 228–231.
  • Kudose, S., et al., 2020. Kidney biopsy findings in patients with COVID-19. Journal of the American Society of Nephrology : JASN, 31 (9), 1959–1968.
  • Kumar, R.N., et al., 2020. COVID‐19 in an HIV‐positive kidney transplant recipient. Transplant infectious disease, 22 (5), e13338.
  • Larsen, C.P., et al., 2020. Collapsing glomerulopathy in a patient with COVID-19. Kidney international reports, 5 (6), 935–939.
  • Lei, S., et al., 2020. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine, 21, 100331.
  • Li, Q., et al., 2020a. Clinical characteristics of SARS-CoV-2 infections involving 325 hospitalized patients outside Wuhan. In Review, preprint.
  • Li, X., et al., 2020b. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of allergy and clinical immunology, 146 (1), 110–118.
  • Li, Y., et al., 2020c. Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study. Critical care (London, England), 24 (1), 314.
  • Lim, J.-H., et al., 2020. Fatal outcomes of COVID-19 in patients with severe acute kidney injury. Journal of clinical medicine, 9 (6), 1718.
  • Luo, P., et al., 2020a. Tocilizumab treatment in COVID-19: a single center experience. Journal of medical virology, 92 (7), 814–818.
  • Luo, X., et al., 2020b. Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China. Epidemiology, preprint.
  • Martino, F., Plebani, M., and Ronco, C., 2020. Kidney transplant programmes during the COVID-19 pandemic. The Lancet. Respiratory medicine, 8 (5), e39.
  • Matthay, M.A., Aldrich, J.M., and Gotts, J.E., 2020. Treatment for severe acute respiratory distress syndrome from COVID-19. The Lancet. Respiratory medicine, 8 (5), 433–434.
  • Mehta, S., et al., 2018. The prognostic importance of duration of AKI: a systematic review and meta-analysis. BMC nephrology, 19 (1), 91
  • Mohamed, M.M.B., et al., 2020. Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney360, 1 (7), 614–622.
  • Nadim, M.K., et al., 2020. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nature reviews nephrology, 16, 747–764.
  • Naughton, C.A., 2008. Drug-induced nephrotoxicity. American family physician, 78 (6), 743–750.
  • Ning, L., et al., 2020. Novel coronavirus (SARS‐CoV‐2) infection in a renal transplant recipient: case report. American journal of transplantation, 20 (7), 1864–1868.
  • Notice, 2012. Kidney international supplements, 2 (1), 1.
  • Ostermann, M., et al., on behalf of the 17th Acute Disease Quality Initiative (ADQI) Consensus Group, 2016. Patient selection and timing of continuous renal replacement therapy. Blood purification, 42 (3), 224–237.
  • Pei, G., et al., 2020. Renal involvement and early prognosis in patients with COVID-19 pneumonia. Journal of the American Society of Nephrology : JASN, 31 (6), 1157–1165.
  • Pelayo, J., et al., 2020. Clinical characteristics and outcomes of community- and hospital-acquired acute kidney injury with COVID-19 in a US inner city hospital system. Cardiorenal medicine, 10 (4), 223–231.
  • Peleg, Y., et al., 2020. Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney international reports, 5 (6), 940–945.
  • Pereira, M.R., et al., 2020. COVID‐19 in solid organ transplant recipients: initial report from the US epicenter. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 20 (7), 1800–1808.
  • Ponce, D., et al., 2020. Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury. Clinical kidney journal, 13 (3), 269–273.
  • Puelles, V.G., et al., 2020. Multiorgan and renal tropism of SARS-CoV-2. The New England journal of medicine, 383 (6), 590–592.
  • Qian, J.-Y., Wang, B., and Liu, B.-C., 2020. Acute kidney injury in the 2019 novel coronavirus disease. Kidney diseases, 6 (5), 318–316.
  • Raina, R., et al., 2020. Kidney replacement therapy in COVID-19 induced kidney failure and septic shock: a pediatric continuous renal replacement therapy [PCRRT] position on emergency preparedness with resource allocation. Frontiers in pediatrics, 8, 413.
  • Ricci, Z., et al., 2006. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion]. Critical care (London, England), 10 (2), R67.
  • Richardson, S., et al., the Northwell COVID-19 Research Consortium, 2020. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA, 323 (20), 2052–2059.
  • Ronco, C., Navalesi, P., and Vincent, J.L., 2020. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. The Lancet. respiratory medicine, 8 (3), 240–241.
  • Ronco, C., Reis, T., and Husain-Syed, F., 2020. Management of acute kidney injury in patients with COVID-19. The Lancet. respiratory medicine, 8 (7), 738–742.
  • Rossi, G.M., et al., 2020. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against “SARS-CoV-2 nephropathy”. Kidney international reports, 5 (7), 1100–1105.
  • Rubin, S., et al., 2020. Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019. Clinical kidney journal, 13 (3), 354–361.
  • Santoriello, D., et al., 2020. Postmortem kidney pathology findings in patients with COVID-19. Journal of the American Society of Nephrology : JASN, 31 (9), 2158–2167.
  • Selby, N.M., et al., 2020. Covid-19 and acute kidney injury in hospital: summary of NICE guidelines. BMJ, 369, m1963.
  • Sharma, P., et al., on behalf of Northwell Nephrology COVID-19 Research Consortium, 2020. COVID-19–associated kidney injury: a case series of kidney biopsy findings. Journal of the American Society of Nephrology : JASN, 31 (9), 1948–1958.
  • Shi, P., et al., 2020a. Clinical characteristics of imported and second-generation COVID-19 cases outside Wuhan, China: a multicenter retrospective study. Infectious Diseases (except HIV/AIDS), preprint.
  • Shi, S., et al., 2020b. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology, 5 (7), 802.
  • Sisó-Almirall, A., et al., 2020. Prognostic factors in Spanish COVID-19 patients: a case series from Barcelona. Primary Care Research, preprint.
  • Su, H., et al., 2020. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney international, 98 (1), 219–227.
  • Sun, J., et al., 2020. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerging microbes & infections, 9 (1), 991–993.
  • Tang, N., et al., 2020. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis : JTH, 18 (5), 1094–1099.
  • Thammathiwat, T., et al., 2020. A case of successful treatment of severe COVID‐19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient. Transplant infectious disease, e13388.
  • The Columbia University Kidney Transplant Program, 2020. Early description of coronavirus 2019 disease in kidney transplant recipients in New York. Journal of the American Society of Nephrology, 31 (6), 1150–1156.
  • Trabulus, S., et al., 2020. Kidney function on admission predicts in-hospital mortality in COVID-19. Plos one, 15 (9): e0238680.
  • Velez, J.C.Q., Caza, T., and Larsen, C.P., 2020. COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19. Nature reviews. Nephrology, 16 (10), 565–567.
  • Wan, S., et al., 2020. Clinical features and treatment of COVID-19 patients in northeast Chongqing. Journal of medical virology, 92 (7), 797–806.
  • Wang, D., et al., 2020a. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323 (11), 1061–1069.
  • Wang, D., et al., 2020b. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Critical care (London, England), 24 (1), 188
  • Wang, L., et al., 2020c. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. Journal of infection, 80 (6), 639–645.
  • Wang, L., et al., 2020d. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. American journal of nephrology, 51 (5), 343–348.
  • Wang, Y., et al., 2020e. Clinical course and outcomes of 344 intensive care patients with COVID-19. American journal of respiratory and critical care medicine, 201 (11), 1430–1434.
  • Work Group Membership, 2012. Kidney international supplements. 2 (1), 2.
  • Xia, T. and Wang, Y., 2020. Coronavirus disease 2019 and transplantation: the combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome. American journal of transplantation, 20 (9), 2630–2631.
  • Xiao, G., et al., 2020. Acute kidney injury in patients hospitalized with COVID-19 in Wuhan, China: a single-center retrospective observational study. Intensive Care and Critical Care Medicine, preprint.
  • Xu, S., et al., 2020. Acute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: a hospital-based retrospective analysis. Urology, preprint.
  • Yan, S., et al., 2020. Clinical characteristics of coronavirus disease 2019 in Hainan, China. Infectious Diseases (except HIV/AIDS), preprint.
  • Yang, L., et al., 2020a. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: a descriptive study. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 129, 104475.
  • Yang, Q., et al., 2020b. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019. Journal of clinical pharmacy and therapeutics, 45 (4), 609–616.
  • Yang, X., et al., 2020c. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet. Respiratory medicine, 8 (5), 475–481.
  • Zhang, G., et al., 2020a. Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. Respiratory Medicine, preprint.
  • Zhang, G., et al., 2020b. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 127, 104364.
  • Zhang, H., et al., 2020c. Identification of kidney transplant recipients with coronavirus disease 2019. European urology, 77 (6), 742–747.
  • Zhang, J., et al., 2020d. [Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 32 (4), 407–411.
  • Zhang, X., et al., 2020e. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. International journal of infectious diseases, 94, 81–87.
  • Zhao, W., et al., 2020a. Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study. Infectious Diseases (except HIV/AIDS), preprint.
  • Zhao, X.-Y., et al., 2020b. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. BMC infectious diseases, 20 (1), 311.
  • Zhou, F., et al., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395 (10229), 1054–1062.
  • Zhu, L., et al., 2020. Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China. European urology, 77 (6), 748–754.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.